logo
#

Latest news with #NivaBupaHealthInsurance

True North, Krishnan Ramachandran sell 10% stake in Niva Bupa Health for Rs 1,507 crore
True North, Krishnan Ramachandran sell 10% stake in Niva Bupa Health for Rs 1,507 crore

Economic Times

time3 days ago

  • Business
  • Economic Times

True North, Krishnan Ramachandran sell 10% stake in Niva Bupa Health for Rs 1,507 crore

Private equity firm True North and Niva Bupa Health Insurance chief Krishnan Ramachandran divested a combined 10 per cent stake in the health insurer for Rs 1,507 crore through open market transactions. ADVERTISEMENT Mumbai-based True North, through its special purpose vehicle Fettle Tone LLP, sold a total of 17.29 crore shares or 9.46 per cent stake in two tranches in Niva Bupa Health Insurance, as per the bulk deal data on BSE. In addition, Niva Bupa Health Insurance MD and CEO Ramachandran offloaded 1 crore shares, representing a 0.55 per cent stake in Gurugram-based Niva Bupa Health Insurance. The shares were sold in the price range of Rs 82.11-82.76 apiece, taking the combined transaction value to Rs 1,507.50 the transaction, Fettle Tone's shareholding in Niva Bupa dipped to 8.01 per cent from 17.47 per cent. Meanwhile, DSP Mutual Fund acquired more than 4.96 crore shares in four tranches or 2.72 per cent stake in Niva Bupa Health Insurance, and SBI Mutual Fund picked up 1.51 crore shares or 0.83 per cent stake in the health insurer. ADVERTISEMENT The shares were purchased at an average price of Rs 82 per piece, taking the aggregate deal value to Rs 531.49 of the other buyers of Niva Bupa Health Insurance's shares could not be ascertained on the BSE. ADVERTISEMENT Also, M Pallonji and Co Pvt Ltd bought more than 1.35 crore shares, amounting to a 0.74 per cent stake in Niva Bupa Health for Rs 113.83 crore, as per the bulk deal data on the National Stock Exchange (NSE).The shares were acquired at an average price of Rs 83.95 apiece. ADVERTISEMENT Details of the sellers of Niva Bupa Health's shares could not be identified on the NSE. Shares of Niva Bupa Health Insurance Company plunged 9.98 per cent to close at Rs 83.07 per piece on BSE, and it declined 9.90 per cent to Rs 83.15 apiece on NSE. PTI (You can now subscribe to our ETMarkets WhatsApp channel)

True North, Krishnan Ramachandran sell 10% stake in Niva Bupa Health for Rs 1,507 crore
True North, Krishnan Ramachandran sell 10% stake in Niva Bupa Health for Rs 1,507 crore

Time of India

time3 days ago

  • Business
  • Time of India

True North, Krishnan Ramachandran sell 10% stake in Niva Bupa Health for Rs 1,507 crore

Private equity firm True North and Niva Bupa Health Insurance chief Krishnan Ramachandran divested a combined 10 per cent stake in the health insurer for Rs 1,507 crore through open market transactions. Mumbai-based True North, through its special purpose vehicle Fettle Tone LLP, sold a total of 17.29 crore shares or 9.46 per cent stake in two tranches in Niva Bupa Health Insurance, as per the bulk deal data on BSE. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Neuropathy & Nerve Damage? Do This Immediately Health Journal Britain Learn More Undo In addition, Niva Bupa Health Insurance MD and CEO Ramachandran offloaded 1 crore shares, representing a 0.55 per cent stake in Gurugram-based Niva Bupa Health Insurance. Play Video Pause Skip Backward Skip Forward Unmute Current Time 0:00 / Duration 0:00 Loaded : 0% 0:00 Stream Type LIVE Seek to live, currently behind live LIVE Remaining Time - 0:00 1x Playback Rate Chapters Chapters Descriptions descriptions off , selected Captions captions settings , opens captions settings dialog captions off , selected Audio Track default , selected Picture-in-Picture Fullscreen This is a modal window. Beginning of dialog window. Escape will cancel and close the window. Text Color White Black Red Green Blue Yellow Magenta Cyan Opacity Opaque Semi-Transparent Text Background Color Black White Red Green Blue Yellow Magenta Cyan Opacity Opaque Semi-Transparent Transparent Caption Area Background Color Black White Red Green Blue Yellow Magenta Cyan Opacity Transparent Semi-Transparent Opaque Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Drop shadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps Reset restore all settings to the default values Done Close Modal Dialog End of dialog window. The shares were sold in the price range of Rs 82.11-82.76 apiece, taking the combined transaction value to Rs 1,507.50 crore. After the transaction, Fettle Tone's shareholding in Niva Bupa dipped to 8.01 per cent from 17.47 per cent. Live Events Meanwhile, DSP Mutual Fund acquired more than 4.96 crore shares in four tranches or 2.72 per cent stake in Niva Bupa Health Insurance, and SBI Mutual Fund picked up 1.51 crore shares or 0.83 per cent stake in the health insurer. The shares were purchased at an average price of Rs 82 per piece, taking the aggregate deal value to Rs 531.49 crore. Details of the other buyers of Niva Bupa Health Insurance's shares could not be ascertained on the BSE. Also, M Pallonji and Co Pvt Ltd bought more than 1.35 crore shares, amounting to a 0.74 per cent stake in Niva Bupa Health for Rs 113.83 crore, as per the bulk deal data on the National Stock Exchange (NSE). The shares were acquired at an average price of Rs 83.95 apiece. Details of the sellers of Niva Bupa Health's shares could not be identified on the NSE. Shares of Niva Bupa Health Insurance Company plunged 9.98 per cent to close at Rs 83.07 per piece on BSE, and it declined 9.90 per cent to Rs 83.15 apiece on NSE. PTI

Niva Bupa shares fall 11% as PE investor sells 12% stake in block deal
Niva Bupa shares fall 11% as PE investor sells 12% stake in block deal

Economic Times

time3 days ago

  • Business
  • Economic Times

Niva Bupa shares fall 11% as PE investor sells 12% stake in block deal

Shares of Niva Bupa Health Insurance slipped as much as 11.1% on Monday to Rs 82 on the BSE after a large block deal involving a 12% equity stake saw 56.3 lakh shares change hands, as per ETNOW. ADVERTISEMENT Ahead of the trade, on June 1, ET NOW reported, citing sources, that homegrown private equity firm True North and Niva Bupa's Managing Director and CEO, Krishnan Ramachandran, were set to offload a combined 132 million shares in the health insurer through a block deal. ETNOW had also reported that Fettle Tone LLP, an investment vehicle of True North, was expected to sell up to 122 million shares, or roughly 6.7% of Niva Bupa's equity. CEO Krishnan Ramachandran was likely to dilute 10 million shares, equating to around 0.5% of the company. The offer price was set at Rs 82 per share, pegging the total size of the transaction at around Rs 1,082 crore. Based on the latest shareholding pattern as of March-end, the company's promoter Bupa holds 55.98% stake, while True North holds 17.47% via Fettle Tone Bupa reported a 31.2% year-on-year rise in net profit for the March quarter, posting Rs 206 crore compared to Rs 157 crore in the same period last year. Gross premiums increased 18% to Rs 2,078.7 crore, while net premiums climbed 21% to Rs 1,672 the insurer's underwriting profit slipped 12.2% year-on-year to Rs 57.6 crore from Rs 65.6 crore. Operating profit also fell sharply by 43.1% to Rs 94.9 crore from Rs 166.8 crore in the year-ago period. Its solvency ratio stood steady at 3.03% on a sequential basis. ADVERTISEMENT Niva Bupa Health Insurance listed on Indian stock exchanges in November 2024, marking the first domestic listing of a pure-play global MNC health insurer backed by British firm Bupa. In September 2023, True North ceded control to Bupa by selling a 20% stake for approximately Rs 2,700 crore. Also read | Ircon International shares jump over 2% after winning Rs 1,068 crore EPC contract from railways (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times) ADVERTISEMENT (You can now subscribe to our ETMarkets WhatsApp channel)

Niva Bupa elevates Nimish Agrawal to director of digital business & CMO
Niva Bupa elevates Nimish Agrawal to director of digital business & CMO

Time of India

time29-05-2025

  • Business
  • Time of India

Niva Bupa elevates Nimish Agrawal to director of digital business & CMO

Niva Bupa Health Insurance has announced the strategic elevation of Nimish Agrawal to the role of director, digital business unit and chief marketing officer (CMO). This expanded mandate sees Agrawal continuing to spearhead the company's comprehensive marketing initiatives while also taking the helm of the Digital Business Unit, recognised as one of Niva Bupa 's most strategic and profitable growth channels. With a distinguished career spanning over two decades in the financial services and insurance sectors, Agrawal brings an experience in brand building, digital transformation , and customer-centric strategies. Prior to this elevation, Agrawal successfully led Niva Bupa's marketing efforts, playing a crucial role in enhancing brand visibility and market penetration. He joined the company in 2021 as SVP and head of marketing and digital sales. In an official press note, Niva Bupa Health Insurance extended its sincere appreciation for Agrawal's unwavering dedication and looks forward to his continued invaluable contributions in this critically important leadership role. He previously served as head of marketing at for over three years, where he led end-to-end marketing initiatives for the recruitment vertical at Info Edge. This included platforms such as FirstNaukri, Naukri FastForward, Naukri Premium, Naukri Learning, and Quadrangle, among others. Prior to that, he spent over three years at AkzoNobel Decorative Coatings, joining in 2014 as senior brand manager and later advancing to category head. In this role, he managed the interior paints portfolio, covering a wide range from entry-level premium products to super-premium offerings, including patterns, designs, and international finishes. He has also held roles at Britannia Industries and Henkel CEE.

Niva Bupa share price rallies over 14% on strong Q4. Time to invest in this health insurance stock?
Niva Bupa share price rallies over 14% on strong Q4. Time to invest in this health insurance stock?

Mint

time08-05-2025

  • Business
  • Mint

Niva Bupa share price rallies over 14% on strong Q4. Time to invest in this health insurance stock?

Stocks in focus today: Shares of Niva Bupa Health Insurance, a recent entrant on Dalal Street, jumped 14.13% in early trade on Thursday, May 8, to hit a 4-month high of ₹ 92.45 apiece, following the release of the company's March quarter results (Q4FY25), which came in above Street estimates. The company reported a 31.2% year-on-year (YoY) increase in net profit, at ₹ 206 crore for the quarter ended March 31, 2025, compared to ₹ 157 crore in Q4FY24. The company's PAT for FY25 rose to ₹ 214 crore, up from ₹ 82 crore in FY24, marking a 161% YoY growth. In Q4FY25, Niva Bupa achieved a Gross Written Premium (GWP) of ₹ 2,395 crore, reflecting a 36% YoY increase. For the full financial year FY25, the company recorded a GWP of ₹ 7,407 crore, registering 32% YoY growth. In terms of retail health market share, the company increased its share from 9.1% in FY24 to 9.4% in FY25, consolidating its position among the top players in the Indian health insurance sector. Niva Bupa also improved its Claims Settlement Ratio from 91.9% in FY24 to 92.4% in FY25. Simultaneously, the company achieved a notable reduction in its Expense of Management, which dropped from 39.3% in FY24 to 37.4% in FY25. Looking ahead, the company said it plans to invest in building a strong and differentiated brand, driving digital transformation, and expanding its distribution channels to further strengthen market presence and deliver superior healthcare protection to millions of Indians. 'Our focus remains on innovating for the customer, simplifying the claims process, and strengthening our digital backbone to drive further efficiencies and scalability,' the company said in its Q4 earnings' filing. Following the company's Q4FY25 results, domestic brokerage firm Kotak Institutional Equities retained its 'Add' rating on the stock with a target price of ₹ 85 per share. However, the stock breached the brokerage's target level during today's session. The brokerage stated that the company is well-positioned to deliver strong growth (26% GWP CAGR over FY2024–27E), continuing its market share gains through a diversified retail product portfolio, a focus on the mass affluent segment, and a well-balanced distribution mix. Improving operating leverage is expected to drive RoE expansion into the high teens over the medium term, supported by its best-in-class claims ratio. Niva Bupa Health Insurance's share price has been gaining momentum on Dalal Street in recent months, delivering a 26% return in less than 3 months. The stock ended the last two months in the green and has extended the rally into the current month, already gaining an additional 12% so far. Niva Bupa Health Insurance is a joint venture between the Bupa Group and Fettle Tone LLP, specializing in health insurance. The company made a decent debut on the stock exchanges on Thursday, November 14, 2024, listing at ₹ 78.14 on the NSE—a 5.5% premium over its issue price of ₹ 74. The initial public offering (IPO), valued at ₹ 2,200 crore, was open for subscription from November 7 to November 11.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store